Prevalencia de diabetes por diagnóstico médico previo en México

Rosalba Rojas(Instituto Nacional de Salud Pública), Tonatiuh Barrientos‐Gutiérrez(Instituto Nacional de Salud Pública), Carlos A. Aguilar‐Salinas(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Emiliano Zárate-Rojas(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Ana Basto‐Abreu(National Institute of Public Health), Salvador Villalpando(Instituto Nacional de Salud Pública)

Salud Pública de México

October 27, 2017

Cited by 143

Related Papers

Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015

|The Lancet|2017|2.1k

Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

|The Lancet|2024|2k

A genomic mutational constraint map using variation in 76,156 human genomes

|Nature|2023|1.3k

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

|European Heart Journal|2021|889

Impact of the Mexican Program for Education, Health, and Nutrition (Progresa) on Rates of Growth and Anemia in Infants and Young Children

|JAMA|2004|399